Battenin (CLN3) Antibody

This product is currently in development. The lead time for this product may be several months. Please contact us at [email protected] for an updated lead time before purchasing this product.

This product is currently in development. The lead time for this product may be several months. Please contact us at [email protected] for an updated lead time before purchasing this product.

This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene.

Target	Battenin (CLN3)
Clonality	Polyclonal
Reactivity	Human
Tested Applications	ELISA, WB
Host	Rabbit
Recommended dilutions	WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	KLH-conjugated synthetic peptide between 235-263 amino acids from the Central region of human CLN3.
Isotype	IgG
Form	Liquid
Purification	Purified through a protein A column, followed by peptide affinity purification.
Storage	Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC	Q13286 (UniProt, ExPASy)
UniProt Entry Name	CLN3_HUMAN
KEGG	hsa:1201
String	9606.ENSP00000454229
Molecular Weight	Calculated MW: 47.6 kDa
Buffer	PBS containing 0.09% sodium azide.
Specificity	Predicted to react with Monkey CLN3.
Availability	Please enquire.
Note	This product is for research use only.

Research Articles on Battenin (CLN3)

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue